Literature DB >> 8948631

Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.

L T Timchenko1, J W Miller, N A Timchenko, D R DeVore, K V Datar, L Lin, R Roberts, C T Caskey, M S Swanson.   

Abstract

Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease that is associated with a (CTG)n repeat expansion in the 3'-untranslated region of the myotonin protein kinase (Mt-PK) gene. This study reports the isolation and characterization of a (CUG)n triplet repeat pre-mRNA/mRNA binding protein that may play an important role in DM pathogenesis. Two HeLa cell proteins, CUG-BP1 and CUG-BP2, have been purified based upon their ability to bind specifically to (CUG)8 oligonucleotides in vitro. While CUG-BP1 is the major (CUG)8-binding activity in normal cells, nuclear CUG-BP2 binding activity increases in DM cells. Both CUG-BP1 and CUG-BP2 have been identified as isoforms of a novel heterogeneous nuclear ribonucleoprotein (hnRNP), hNab50. The CUG-BP/hNab50 protein is localized predominantly in the nucleus and is associated with polyadenylated RNAs in vivo. In vitro RNA-binding/photocrosslinking studies demonstrate that CUG-BP/hNab50 binds to RNAs containing the Mt-PK 3'-UTR. We propose that the (CUG)n repeat region in Mt-PK mRNA is a binding site for CUG-BP/hNab50 in vivo, and triplet repeat expansion leads to sequestration of this hnRNP on mutant Mt-PK transcripts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948631      PMCID: PMC146274          DOI: 10.1093/nar/24.22.4407

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Gene expression in the embryonic nervous system of Xenopus laevis.

Authors:  K Richter; H Grunz; I B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Activation of the human beta-interferon gene requires an interferon-inducible factor.

Authors:  T Enoch; K Zinn; T Maniatis
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.

Authors:  L T Timchenko; N A Timchenko; C T Caskey; R Roberts
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

4.  Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy.

Authors:  S Reddy; D B Smith; M M Rich; J M Leferovich; P Reilly; B M Davis; K Tran; H Rayburn; R Bronson; D Cros; R J Balice-Gordon; D Housman
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

5.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.

Authors:  G Jansen; P J Groenen; D Bächner; P H Jap; M Coerwinkel; F Oerlemans; W van den Broek; B Gohlsch; D Pette; J J Plomp; P C Molenaar; M G Nederhoff; C J van Echteld; M Dekker; A Berns; H Hameister; B Wieringa
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

6.  TRAP, the trp RNA-binding attenuation protein of Bacillus subtilis, is a toroid-shaped molecule that binds transcripts containing GAG or UAG repeats separated by two nucleotides.

Authors:  P Babitzke; D G Bear; C Yanofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 7.  Trinucleotide repeat expansion and human disease.

Authors:  C T Ashley; S T Warren
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

Review 8.  Trinucleotide repeats in neurogenetic disorders.

Authors:  H L Paulson; K H Fischbeck
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

9.  Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus.

Authors:  G Jansen; D Bächner; M Coerwinkel; N Wormskamp; H Hameister; B Wieringa
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

10.  A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts.

Authors:  S Piñol-Roma; M S Swanson; J G Gall; G Dreyfuss
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  196 in total

1.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

Review 2.  Cytoplasmic polyadenylation in development and beyond.

Authors:  J D Richter
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

3.  Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation.

Authors:  G Raca; E Y Siyanova; C T McMurray; S M Mirkin
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 4.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

5.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 6.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

7.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

Review 8.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

9.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 10.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.